Big names from Pfizer, Allergan ride wave of biotech blank-check deals in 2020
Dec 11, 2020 - SNL Financial
Mergers and Acquisitions-Partnership Announcement
With a surge of capital in an uncertain market and very few places to spend it, investors are looking to special purpose acquisition companies to bring biotech companies public in a non-traditional way.
Allergan's former CEO, Brent Saunders, is back in the aesthetics business after Vesper Healthcare Acquisition Corp.'s $975 million purchase of The HydraFacial Co.
Pfizer Inc. and Bain Capital LP's neuroscience spin off Cerevel Therapeutics Holdings Inc. is picked up by ARYA Sciences A...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
